Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
-
* Corresponding author: Dario Neri dario.neri@pharma.ethz.ch
Arthritis Research & Therapy 2009, 11:R142 doi:10.1186/ar2814
Accesses
- Last 30 days: 84 accesses
- Last year: 813 accesses
- All time: 3094 accesses
Cited by
BioMed Central: 2 citations
|
Elisa Ventura, Enrica Balza, Laura Borsi, Giorgia Tutolo, Barbara Carnemolla, Patrizia Castellani, Luciano Zardi BMC Biotechnology 2011, 11:104 (10 November 2011) |
|
Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis? Fons van de Loo, Wim van den Berg Arthritis Research & Therapy 2009, 11:132 (6 November 2009) |